Can Spire Healthcare’s strategic review revive its share price?
Few issues can jolt a moribund share value into life like a strategic review. When Spire Healthcare (SPI), the UK’s second-largest non-public healthcare supplier, introduced one in September, its shares climbed 14 per cent. However, seven months later – and with no decision in sight – the inventory has shed 1 / 4 of its…
